Aclaris Therapeutics (ACRS) Asset Utilization Ratio (2018 - 2025)
Historic Asset Utilization Ratio for Aclaris Therapeutics (ACRS) over the last 9 years, with Q3 2025 value amounting to 0.09.
- Aclaris Therapeutics' Asset Utilization Ratio fell 4525.04% to 0.09 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.09, marking a year-over-year decrease of 4525.04%. This contributed to the annual value of 0.09 for FY2024, which is 3517.97% down from last year.
- Per Aclaris Therapeutics' latest filing, its Asset Utilization Ratio stood at 0.09 for Q3 2025, which was down 4525.04% from 0.09 recorded in Q2 2025.
- In the past 5 years, Aclaris Therapeutics' Asset Utilization Ratio registered a high of 0.19 during Q2 2024, and its lowest value of 0.02 during Q2 2022.
- Moreover, its 5-year median value for Asset Utilization Ratio was 0.09 (2025), whereas its average is 0.09.
- In the last 5 years, Aclaris Therapeutics' Asset Utilization Ratio tumbled by 7108.49% in 2021 and then skyrocketed by 45023.74% in 2023.
- Quarter analysis of 5 years shows Aclaris Therapeutics' Asset Utilization Ratio stood at 0.03 in 2021, then soared by 333.71% to 0.11 in 2022, then surged by 31.93% to 0.15 in 2023, then crashed by 38.15% to 0.09 in 2024, then dropped by 7.14% to 0.09 in 2025.
- Its Asset Utilization Ratio stands at 0.09 for Q3 2025, versus 0.09 for Q2 2025 and 0.08 for Q1 2025.